Description

First
Quarter

Second
Quarter

Third
Quarter

Fourth
Quarter

Fiscal 2025

Net sales

$

53,725

$

49,491

$

53,804

$

51,889

Gross profit

16,426

15,326

16,673

16,375

Net income (loss)

590

(751

)

(2,057

)

(1)

1,075

Net income (loss) per share:

Common stock - basic

$

0.04

$

(0.05

)

$

(0.15

)

$

0.08

Class B common stock - basic

0.04

(0.05

)

(0.13

)

0.07

Common stock - diluted

0.04

(0.05

)

(0.15

)

0.08

Class B common stock - diluted

0.04

(0.05

)

(0.13

)

0.07

(1) Reported loss includes a $3.6 million
         disposal loss on healthcare assets.

Fiscal 2024

Net sales

$

52,581

$

44,130

$

52,375

$

47,374

Gross profit

17,264

12,542

15,436

14,724

Net income (loss)

1,227

(1,797

)

750

(119

)

Net income (loss) per share:

Common stock - basic

$

0.09

$

(0.13

)

$

0.05

$

(0.01

)

Class B common stock - basic

0.08

(0.12

)

0.05

(0.01

)

Common stock - diluted

0.09

(0.13

)

0.05

(0.01

)

Class B common stock - diluted

0.08

(0.12

)

0.05

(0.01

)